newsfilter
← Latest News
GlobeNewswire·

Cerevel Therapeutics to Present at the Stifel 2023 CNS Days

CAMBRIDGE, Mass., March 21, 2023 (GLOBE NEWSWIRE) -- Cerevel Therapeutics, (NASDAQ:CERE), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, today announced that chairperson